Emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomes.
Affiliation
Departments of Acute Medicine, Endocrinology and Medical Oncology, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2018-10-23
Metadata
Show full item recordCitation
Emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomes. 2018 CancerJournal
CancerDOI
10.1002/cncr.31789PubMed ID
30351448Type
ArticleLanguage
enISSN
1097-0142ae974a485f413a2113503eed53cd6c53
10.1002/cncr.31789
Scopus Count
Collections
Related articles
- Reply to emergency management of immune-related hypophysitis: Collaboration between specialists is essential to achieve optimal outcomes.
- Authors: Faje AT, Sullivan RJ
- Issue date: 2018 Dec 15
- Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.
- Authors: Tiu C, Pezaro C, Davis ID, Grossmann M, Parente P
- Issue date: 2015 Jun
- Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab.
- Authors: Brilli L, Danielli R, Ciuoli C, Calabrò L, Di Giacomo AM, Cerase A, Paffetti P, Sestini F, Porcelli B, Maio M, Pacini F
- Issue date: 2017 Dec
- Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma.
- Authors: Albarel F, Gaudy C, Castinetti F, Carré T, Morange I, Conte-Devolx B, Grob JJ, Brue T
- Issue date: 2015 Feb
- Toxicities and outcomes: Do steroids matter?
- Authors: Johnson DB
- Issue date: 2018 Sep 15